Metoclopramide Accord (Metoclopramide Hydrochloride Anhydrous)

The drug blocks dopamine D2 receptors in the brain’s chemoreceptor trigger zone, reducing the urge to vomit, while simultaneously increasing acetylcholine activity in the gastrointestinal tract, which stimulates smooth‑muscle contraction and speeds gastric emptying.

The appropriate dose is individualized by the prescribing clinician based on the patient’s age, weight, renal and hepatic function, and the specific condition being treated. No universal dosing regimen is provided here.

Safety data for Metoclopramide during pregnancy and lactation are limited. Clinicians should weigh potential benefits against possible risks and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoclopramide differs from many antiemetics by combining anti‑nausea activity with pro‑kinetic effects. Unlike pure serotonin antagonists, it also enhances gastric motility, making it useful for conditions such as gastroparesis, but it carries a distinct risk profile for extrapyramidal symptoms.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Metoclopramide Accord is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

The most concerning adverse events include extrapyramidal reactions such as dystonia or tardive dyskinesia, neuroleptic malignant syndrome, severe depression or suicidal thoughts, and rare anaphylactic responses. Prompt medical attention is required if any of these occur.

Patients with known hypersensitivity to metoclopramide, those taking monoamine oxidase inhibitors, individuals with a history of severe movement disorders, and patients with uncontrolled epilepsy should avoid this medication unless a specialist advises otherwise.